Alzheimer’s Drug Discovery Foundation Invests in First-of-its-Kind Biomarker Observatory Led by Renowned Clinical Trials Expert to Accelerate Novel Drug Development

Posted on by

Led by Dr. Jeffrey Cummings, the Observatory will enable broader access to the biomarker pipeline, accelerating the development of novel drugs that will be used in combination with available drugs on the market. NEW YORK, Sept. 18, 2024 /PRNewswire/ — The Alzheimer’s Drug Discovery…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.